A multi-epitope vaccine targeting a key virulence factor ClfA: An In-silico approach to combat Staphylococcus aureus infections
PLOS One · 2025
DOI: 10.1371/journal.pone.0334885 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Md Nipatul Hasan Nirob und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Staphylococcus aureus, Virulence Factors, Staphylococcal Infections, Staphylococcal Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Staphylococcus aureus, a gram-positive opportunistic pathogen, presents a growing global threat due to the rise of multidrug-resistant (MDR) strains. To counter this, we designed a multi-epitope vaccine (MEV) targeting the ClfA virulence protein using an integrative in silico approach. Sixty-one conserved epitopes (19 CTL, 36 HTL, 6 LBL) were selected based on antigenicity, immunogenicity, non-toxicity, and lack of homology to human proteins. These epitopes demonstrated strong HLA-binding affinities and over 50% global population coverage, indicating broad immunological applicability. Molecular docking revealed the strongest binding between the MEV and TLR4, with a ΔG of –17.1 kcal/mol and an exceptionally low dissociation constant (2.6 × 10 ⁻ ¹² M). HADDOCK 2.4-supported docking scores corroborated these results. Molecular dynamics (MD) simulations and MM/GBSA analysis further assessed the structural behavior of the MEV in complex with TLR2, TLR3, and TLR4. While TLR2 and TLR3 complexes showed greater structural stability (RMSF ~0.2–0.5 nm), the TLR4 complex exhibited higher flexibility (RMSF ~2.5 nm) but yielded the most favorable binding free energy (ΔG = –174.41 kcal/mol), suggesting stronger overall interaction. The TLR2–vaccine complex formed ~370–400 hydrogen bonds on average, while the unbound vaccine maintained ~60–70 internal hydrogen bonds, confirming structural integrity. Radius of gyration (Rg) and solvent-accessible surface area (SASA) analyses revealed that TLR2 and TLR3 binding induced compact and stable structures, whereas the TLR4 complex was more solvent-exposed and flexible. Disulfide bond engineering (VAL32–THR37 and PHE45–ASN64) enhanced vaccine stability, further supported by favorable physicochemical parameters (MW 54.67 kDa, pI 7.78, instability index 19.78). The low eigenvalue (3.63 × 10 ⁻ ⁶) indicated high structural mobility, associated with efficient energy absorption. Codon optimization (GC content 53.33%, CAI 0.96) predicted high expression potential in E. coli , and in silico cloning was successfully performed using the pET-28a(+) vector. Immune simulation demonstrated robust humoral and cellular responses, including elevated levels of IgM, IgG1, IFN-γ, and increased B and T cell populations. Collectively, these findings suggest that the designed MEV is structurally stable, immunogenic, and capable of eliciting a potent immune response, with TLR4 emerging as a promising innate immune target. Further experimental validation and in vivo studies are essential to confirm its efficacy and safety as a vaccine candidate against S. aureus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, Bangladesh.
- Padma Bioresearch, Dhaka, Bangladesh.
- Department of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh.
- Department of Botany, Jahangirnagar University, Savar, Dhaka, Bangladesh.
- Department of Biochemistry and Molecular Biology, Jahangirnagar University, Savar, Dhaka, Bangladesh.
ORCID-Profile: Md Nipatul Hasan Nirob, Md Sazidul Islam, Aparna Shil
Zitieren
APA
Nirob, M. N. H., Sultana, I., Al Arian, T., Islam, M. S., Moniruzzzaman, M., Nosi, S. J., Halder, S. K., Shil, A., & Himel, M. K. (2025). A multi-epitope vaccine targeting a key virulence factor ClfA: An In-silico approach to combat Staphylococcus aureus infections. PLOS One. https://doi.org/10.1371/journal.pone.0334885
Vancouver
Nirob MNH, Sultana I, Al Arian T, Islam MS, Moniruzzzaman M, Nosi SJ, et al. A multi-epitope vaccine targeting a key virulence factor ClfA: An In-silico approach to combat Staphylococcus aureus infections. PLOS One. 2025. doi:10.1371/journal.pone.0334885
BibTeX
@article{Nirob2025,
author = {Nirob, Md Nipatul Hasan and Sultana, Ive and Al Arian, Tawsif and Islam, Md Sazidul and Moniruzzzaman, Md and Nosi, Safia Jerin and Halder, Sajal Kumar and Shil, Aparna and Himel, Mahbubul Kabir},
title = {A multi-epitope vaccine targeting a key virulence factor ClfA: An In-silico approach to combat Staphylococcus aureus infections},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0334885}
}
EUVIMED